(Q32159956)

6 July 2017

TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis (English)

1 reference

6 July 2017

B Seifert

3

0 references

author name string

J Kamarashev

1

1 reference

6 July 2017

S Ferrone

2

1 reference

6 July 2017

R Böni

4

1 reference

6 July 2017

F O Nestle

5

1 reference

6 July 2017

G Burg

6

1 reference

6 July 2017

R Dummer

7

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

International Journal of Cancer

6 July 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

6 July 2017

95

1 reference

6 July 2017

1

1 reference

6 July 2017

23-28

1 reference

Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression

6 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Direct evidence to support the immunosurveillance concept in a human regressive melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Peptide antigen production by the proteasome: complexity provides efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Constant detection of surface and cytoplasmic immunoglobulin heavy and light chain expression in formalin-fixed and paraffin-embedded material

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

How does TAP associate with MHC class I molecules?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

T-cell recognition of human melanoma antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

MHC-linked LMP gene products specifically alter peptidase activities of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

HLA-DR Antigen Expression in Primary Melanomas of the Skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Immunologic recognition of malignant melanoma by autologous T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Combined interferon-alpha and interleukin-2 as adjuvant treatment for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

TAP expression provides a general method for improving the recognition of malignant cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010120%2995%3A1%3C23%3A%3AAID-IJC1004%3E3.0.CO%3B2-4

10.1002/1097-0215(20010120)95:1<23::AID-IJC1004>3.0.CO;2-4

21 January 2018

Identifiers

DOI

1 reference

6 July 2017

1 reference